|
|
Preparation and Preliminary Application of Human Protein DFF45 Polyclonal Antibody |
Tianjin Life Science Research Center Basic Medical School of Tianjin Medical University, Tianjin 300070, China |
|
|
Abstract To express and purify the fusion protein of GST-tagged DNA fragmentation factor 45(DFF45) in prokaryocytes and prepare anti-DFF45 polyclonal antibody. The expression plasmid pGEX-5X-1/DFF45 was constructed and transformed into E.coli BL21, and the expression of GST-DFF45 protein was induced by IPTG. After purification, the fusion protein GST-DFF45 was used to immunize Oryctolagus cuniculus to obtain the antibody serum. Then the anti-DFF45 serum was purified by CNBr-activated Sepharose? 4B. The titer of the polyclonal antibody was detected by ELISA and its specificity was analyzed by Western blotting and immunofluorescence. Furthermore, we detected the expression of DFF45 protein in several human cell lines, and observed the cellular localization of DFF45 protein. The fusion protein was successfully expressed and purified, and the specific polyclonal antibody was prepared. The titer of the polyclonal antibody was up to 1:20 000 detected by ELISA, and the high specificity of the antibody was confirmed by Western blotting and immunofluorescence. Moreover, we found that DFF45 protein showed differential expression in several human cell lines. We also found that DFF45 protein was located in both cytoplasm and nucleus. The successful preparation of DFF45 polyclonal antibody and the confirmation of its different expression levels in human cells provides a tool for the further study of the relation between DFF45 and tumors.
|
Received: 26 November 2009
Published: 26 February 2010
|
|
|
[1] 凌诒萍.细胞生物学.北京:人民卫生出版社,2001.234242. Ling Y P. Cell Biology. Beijing: People’s Medical Publishing House,2001.234242.
[2] Enari M , Sokahira H, Yokoyama H, et al. A caspaseactivated DNase that degrades DNA during apoptosis, and its inhibitor ICAD. Nature,1998,391(6662): 4350.
[3] McCarty J S, Toh S Y, Li P. Multiple domains of DFF45 bind synergistically to DFF40: roles of caspase cleavage and sequestration of activator domain of DFF40. Biochem Biophys Res Commun,1999,264(1):181185.
[4] 梁素美,陈洪雷,柯尊富,等. Caspase3及其底物 DFF45在人肺癌组织中的表达及意义.中国肿瘤临床,2005,32(12):666669. Liang S M, Chen H L, Ke Z F, et al. Chinese Journal of Clinical Oncology, 2005,32(12):666669.
[5] 余映,田慧军. Caspase3及其底物DFF45在大肠腺癌组织中的表达和意义.现代肿瘤医学,2008,16(4):609611. Yu Y, Tian H J. Modern Oncology, 2008,16(4):609611.
[6] Depraetere V, Golstein P. Dismantling in cell death:molecular mechanisms and relationship to caspase activation. Scand J Immunol,1998,47(6):523531.
[7] Boulares A H, Zoltoski A J, Yakovlev A, et a1. Roles of DNA fragmentation factor and poly(ADPribose) polymerase in an amplification phase of tumor necrosis factorinduced apoptosis. J Biol Chem,2001,276(41):38185 38192.
[8] Zhou P, Lugovskoy A A, McCarty J S, et al. Solution structure of DFF40 and DFF45 Nterminal domain complex and mutual chaperone activity of DFF40 and DFF45. Proc Natl Acad Sci U S A,2001,98(11):60516055.
[9] Charrier L, Jarry A, Toquet C, et al. Growth phasedependent expression of ICADL/DFF45 modulates the pattern of apoptosis in human colonic cancer cells. Cancer Res,2002,62(7):21692174.
[10] Rajandram R, Pat B K, Li J, et al. Expression of apoptotic tumour necrosis factor receptorassociated factor, caspase recruitment domain and cell deathinducing DFF45 effector genes in therapytreated renal cell carcinoma. Nephrology,2009,14(2):205212.
[11] Ejeskr K, Fransson S, Zaibak F, et al. Method for efficient transfection of in vitrotranscribed mRNA into SKNAS and HEK293 cells: difference in the toxicity of nuclear EGF Pcompared to cytoplasmic EGFP. Int J Mol Med,2006,17(6):10111016. |
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|